Clinical Trial Update: Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transfer for preventing recurrent urinary tract infections in women has completed; results are not detailed i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Recurrent Urinary Tract Infections in Women | Phase 2 | Status: COMPLETED